Sunday, August 25, 2019

USFDA issues one observation for Unichem#39;s Ghaziabad formulations facility

USFDA issues one observation for Unichem#39;s Ghaziabad formulations facility "The United States Food and Drug Administration (USFDA) conducted inspection at the company#39;s Ghaziabad formulation facility between August 19, 2019 to August 23, 2019. The inspection was a routine Good manufacturing practice (GMP) surveillance," Unichem said in a regulatory filing.

from Moneycontrol Business News https://ift.tt/2L47Y8U
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

FII exodus deepens in 2026 at Rs 1.75 lakh crore as April outflows swell to Rs 43,967 crore; FOMC next trigger

Foreign institutional investors offloaded Indian equities worth Rs 17,140 crore last week, extending April's outflows to Rs 43,967 crore...